Five projects share £100m UK-US Cancer Grand Challenges fund
Five scientific teams will receive up to £20m each in a new round of funding under the UK and US Cancer Grand Challenges initiative.
Newsletters and Deep Dive digital magazine
Five scientific teams will receive up to £20m each in a new round of funding under the UK and US Cancer Grand Challenges initiative.
Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.
Kyowa Kirin has terminated all clinical trials of its anti-OX40L antibody rocatinlimab, after cases of cancer were seen in patients taking the drug.
The UK has awarded nearly £50m in funding for equipment to help the NHS carry out commercial clinical trials, with a focus on primary care capacity.
Read how Jan-Feb '26 offered a revealing cross-section of how R&D is evolving across therapy areas.
Editor's Picks
Newsletters and Deep Dive
digital magazine